Fred Martin
Disciplined Growth Investors
Fred Martin Eli Lilly and Company stake
total: 241
Disciplined Growth Investors LLY trades
- Total transactions:
- 2
- New positions:
- 1
- Sold out:
- 1
- Held since:
- 2021 Q1
- Held for:
- 1 quarter
- Latest activity:
- 2021 Q2
According to 2026 Q2 report, Fred Martin doesn't hold any Eli Lilly and Company (LLY) shares. To date, the estimated cost basis is nearly $187.09 for "buy" trades and estimated average "sell" price is $187.09. Disciplined Growth Investors first purchased LLY in 2021 Q1, initially acquiring 1,208 shares. Since the initial investment in Eli Lilly and Company (LLY), Disciplined Growth Investors has made 1 more transaction.
When did Fred Martin sell Eli Lilly and Company (LLY)?
Fred Martin sold off the entire Eli Lilly and Company (LLY) position in 2021 Q2.
When did Fred Martin buy Eli Lilly and Company (LLY)?
Fred Martin first invested in Eli Lilly and Company (LLY) in 2021 Q1 at the reported quarter-end price of $187.09 per share.
What's the cost basis of Disciplined Growth Investors's LLY stake?
The estimated cost basis for Eli Lilly and Company (LLY) stake is around $187.09 per share. This represents their average reported price* across all buy transactions
Estimated cost basis*
- Weighted AVG buy price:
- $187.09
- Weighted AVG sell price:
- $187.09
Fred Martin's historical trades in Eli Lilly and Company
2 results
| Period |
% of portfolio |
Shares held after* |
Reported price* |
Value* |
% (shares) of activity |
% change to portfolio |
|---|---|---|---|---|---|---|
|
2021 Q2
|
0.00%
|
0
|
$187.09
|
|
-100% (-1,208)
|
-0%
|
|
2021 Q1
|
0.00%
|
1,208
|
$187.09
|
$226,000
|
new
|
+0%
|
* Shares, change to shares, sold shares, shares held after: split-adjusted.
* Reported price: this doesn't represent the actual buy or sell price. It is the split-adjusted price of the security as of the last day of the reported period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
If the security is completely sold out, we show the reported split-adjusted price prior to the actual period.
* Estimated cost basis: based on "Reported price*" (not earlier than 2013 Q2). Calculation starts from the latest "new buy" activity to the latest "close out" activity (if any).
* Value or Price: If the security is completely sold out, we show the reported value (or price) prior to the actual period.
* New buy or own: this means there is no earlier reporting (for us or in general). So we can't know if the actual purchase of the security happened at the reported period or earlier.